Article
dCK Expression and Gene Polymorphism With Gemcitabine Chemosensitivity in Patients With Pancreatic Ductal Adenocarcinoma: A Strobe-Compliant Observational Study.
Medicine - 1 Mar 2016
Xiong Junjie, Altaf Kiran, Ke Nengwen, Wang Yichao, Tang Jie, Tan Chunlu, Li Ang, Zhang Hao, He Du, Liu Xubao
Abstract excerpt
The aim of this study was to investigate the relationship of deoxycytidine kinase (dCK) protein expression and gene single-nucleotide polymorphisms to gemcitabine chemosensitivity in patients with pancreatic ductal adenocarcinoma (PDAC).In total, 54 patients with resectable PDAC, who received postoperative gemcitabine-based therapy, were enrolled in this study, from January 2011 to April 2013. The dCK protein...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
